news aktuell GmbH

EU-Member states should agree to EU Due Diligence Directive

Dela

Berlin. The German Institute for Human Rights urges the German Government and all other EU member states to vote in favour of the EU Corporate Sustainability Due Diligence Directive (CSDDD) in the final vote on 9 February. The EU directive is critical to safeguard and protect human rights and the environment in global supply chains. After lengthy negotiations, the CSDDD may now fail due to disagreements within the German Government and other EU member states.

The CSDDD is intended to finally harmonise national legislation. "If this is not successful, companies in Europe will be faced with a patchwork of national due diligence regulations in the future, combined with more bureaucracy," says Michael Windfuhr, Deputy Director of the Institute. A number of EU member states and neighbouring countries have already introduced supply chain regulations at national level, such as France and Norway, or are in the process of doing so, such as the Netherlands.

The German Supply Chain Act has now been in force for a year. It is too early to make evidence-based statements about the impact of the law on global markets, but company surveys paint a positive picture. According to a representative survey of 2,000 companies in Germany conducted by the Handelsblatt Research Institute on behalf of Creditreform, only seven per cent of companies reject an obligation to comply with human rights and environmental standards in their supply chains.

At EU level, the EU Sustainability Reporting Directive will also come into force from 2024, initially obliging large companies to report on sustainability aspects in a standardised manner. This reporting standard will also apply to companies under the CSDDD, meaning that the additional reporting effort for the CSDDD will be moderate.

The German Institute for Human Rights is the independent National Human Rights Institution of Germany.

FURTHER INFORMATION

European Network of National Human Rights Institutions, ENNHRI (2023): Statement in the Context of the EU Trilogue Concerning the EU Corporate Sustainability Due Diligence Directive

Contact:
Bettina Hildebrand
Press Officer
Zimmerstraße 26/27
10969 Berlin
Tel.:+49 30 259 359-14
E-Mail:hildebrand@dimr.de

WEB: www.institut-fuer-menschenrechte.de

Nyckelord

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Följ news aktuell GmbH

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från news aktuell GmbH

Companies of Schwarz Group and Google to Sign Partnership to Jointly Deliver Sovereign, Secure Workplace Productivity Solutions for Germany and Europe14.11.2024 16:09:46 CET | Press Release

Schwarz Digits’ Cloud STACKIT will provide local data storage for Google Workspace and offer client-side encryption, delivering a sovereign and secure workplace productivity solution with XM Cyber as enhanced security layer. The partnership will integrate XM Cyber’s Continuous Exposure Management with Google Cloud’s Security portfolio to develop new joint security offerings targeted at public and private sector organizations. The companies of Schwarz Group with 575,000 employees will transition to Google Workspace to maximize security, efficiency, and control of its data sovereignty.

GEMA files model action to clarify AI providers‘ remuneration obligations in Europe13.11.2024 11:11:13 CET | Press Release

GEMA is the first collecting society worldwide to file a lawsuit against a provider of generative artificial intelligence (AI) systems for the unlicensed use of protected musical works. Specifically, it concerns the US company OpenAI, the autogenerative chatbot systems operator. GEMA accuses OpenAI of reproducing protected song lyrics by German authors without having acquired licenses or paid the authors in question. The aim is to prove that OpenAI systematically uses GEMA's repertoire to train its systems.

HEIDELBERG anticipates a very strong second half to financial year 2024/202513.11.2024 08:06:09 CET | Press Release

Incoming orders after six months above previous year’s level thanks to strong drupa orders High order backlog provides sound basis for projected sales volume in second half of the year, capacities being fully utilized Strong seasonality in financial year, with sales and EBITDA in the first half of the year within expectations Packaging solutions segment remains growth driver Annual forecast confirmed

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain7.11.2024 11:04:10 CET | Press Release

The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures per year in the U.S.[2] QUTENZA® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Topline results are expected in Q4 2025 and Averitas Pharma aims to submit a supplemental new drug application (sNDA) for a US label extension in 2026, subject to positive data.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum
HiddenA line styled icon from Orion Icon Library.Eye